Advertisement

Topics

Human medicines European public assessment report (EPAR): Dacogen, decitabine, Leukemia, Myeloid, Date of authorisation: 20/09/2012, Revision: 13, Status: Authorised

10:00 EDT 13 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Dacogen, decitabine, Leukemia, Myeloid, Date of authorisation: 20/09/2012, Revision: 13, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Dacogen, decitabine, Leukemia, Myeloid, Date of authorisation: 20/09/2012, Revision: 13, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Dacogen, decitabine, Leukemia, Myeloid, Date of authorisation: 20/09/2012, Revision: 13, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...